Sienna Biopharmaceuticals (SNNA) PT Lowered to $3 at BMO Capital Sep 5, 2019 06:53AM
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference Jun 20, 2019 09:05AM
Sienna Biopharmaceuticals (SNNA) PT Lowered to $9 at BMO Capital May 13, 2019 07:54AM
Sienna Biopharmaceuticals (SNNA) Prices 8M Share Common Stock Offering at $2.50/Share Feb 20, 2019 08:05AM
Sienna Biopharmaceuticals Prices Public Offering of Common Stock Feb 20, 2019 08:01AM


Feb 19, 2019 04:13PM Sienna Biopharmaceuticals (SNNA) Commences Public Offering of Common Stock
Feb 19, 2019 04:10PM Sienna Biopharmaceuticals Announces Proposed Public Offering of Common Stock
Dec 6, 2018 04:05PM Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
Dec 4, 2018 07:53AM Sienna Biopharmaceuticals (SNNA) PT Lowered to $17 at BMO Capital
Dec 11, 2017 09:05AM Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
Aug 21, 2017 02:55AM BMO Capital Starts Sienna Biopharmaceuticals (SNNA) at Outperform
Aug 1, 2017 04:05PM Sienna Biopharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 27, 2017 10:33AM Sienna Biopharmaceuticals (SNNA) IPO Opens Sharply Higher
Jul 27, 2017 05:46AM Sienna Biopharmaceuticals (SNNA) Prices 4.33M Share IPO at $15/Sh
Jul 26, 2017 07:30PM Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock